The Change of Serum Myostain in Patients with Hyperthyroidism
碩士 === 國立臺灣大學 === 臨床醫學研究所 === 100 === Objectives: Myostatin, a negative regulator of skeletal muscle growth, may modulate muscle in myopathy after development. Background: Both hypothyroidism and hyperthyroidism may cause signs and symptoms of neuromuscular dysfunction. We hypothesized that serum m...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/32047959671498849948 |
id |
ndltd-TW-100NTU05521025 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-100NTU055210252015-10-13T21:50:17Z http://ndltd.ncl.edu.tw/handle/32047959671498849948 The Change of Serum Myostain in Patients with Hyperthyroidism 血清中的肌肉生長抑制素於甲狀腺機能亢進的變化 Wei-Che chen 陳偉哲 碩士 國立臺灣大學 臨床醫學研究所 100 Objectives: Myostatin, a negative regulator of skeletal muscle growth, may modulate muscle in myopathy after development. Background: Both hypothyroidism and hyperthyroidism may cause signs and symptoms of neuromuscular dysfunction. We hypothesized that serum myostatin level might be related to myopathy in hyperthyroidism. Method: We measure serum myostatin level in patients with hyperthyroidism and normal control, and check serum myostatin again after anti-thyroid drugs used in patients with hyperthyroidism for 24 weeks. . Results There is no elevation of serum myostatin level but elevated serum IGF-1 level, compared to euthyroidism. After anti-thyroid medication for 24 weeks, no significant increase of serum myostatin protein levels was found and the serum IGF-1 level also had no obvious change. 11 of 24 patients have decrease of serum myostatin protein levels after medication for 24 weeks Conclusions: There are no changes in myostatin level before and after medication. Serum IGF-1 increase in patients with hyperthyroidism and no change after treatment. Advanced measurement of serum and muscle myostatin protein, myostatin mRNA, follistatin and other muscle related markers in more cases could be done. Wei-Shiung Yang 楊偉勛 2012 學位論文 ; thesis 28 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立臺灣大學 === 臨床醫學研究所 === 100 === Objectives: Myostatin, a negative regulator of skeletal muscle growth, may modulate muscle in myopathy after development.
Background: Both hypothyroidism and hyperthyroidism may cause signs and symptoms of neuromuscular dysfunction. We hypothesized that serum myostatin level might be related to myopathy in hyperthyroidism.
Method: We measure serum myostatin level in patients with hyperthyroidism and normal control, and check serum myostatin again after anti-thyroid drugs used in patients with hyperthyroidism for 24 weeks. .
Results There is no elevation of serum myostatin level but elevated serum IGF-1 level, compared to euthyroidism. After anti-thyroid medication for 24 weeks, no significant increase of serum myostatin protein levels was found and the serum IGF-1 level also had no obvious change. 11 of 24 patients have decrease of serum myostatin protein levels after medication for 24 weeks
Conclusions: There are no changes in myostatin level before and after medication. Serum IGF-1 increase in patients with hyperthyroidism and no change after treatment. Advanced measurement of serum and muscle myostatin protein, myostatin mRNA, follistatin and other muscle related markers in more cases could be done.
|
author2 |
Wei-Shiung Yang |
author_facet |
Wei-Shiung Yang Wei-Che chen 陳偉哲 |
author |
Wei-Che chen 陳偉哲 |
spellingShingle |
Wei-Che chen 陳偉哲 The Change of Serum Myostain in Patients with Hyperthyroidism |
author_sort |
Wei-Che chen |
title |
The Change of Serum Myostain in Patients with Hyperthyroidism |
title_short |
The Change of Serum Myostain in Patients with Hyperthyroidism |
title_full |
The Change of Serum Myostain in Patients with Hyperthyroidism |
title_fullStr |
The Change of Serum Myostain in Patients with Hyperthyroidism |
title_full_unstemmed |
The Change of Serum Myostain in Patients with Hyperthyroidism |
title_sort |
change of serum myostain in patients with hyperthyroidism |
publishDate |
2012 |
url |
http://ndltd.ncl.edu.tw/handle/32047959671498849948 |
work_keys_str_mv |
AT weichechen thechangeofserummyostaininpatientswithhyperthyroidism AT chénwěizhé thechangeofserummyostaininpatientswithhyperthyroidism AT weichechen xuèqīngzhōngdejīròushēngzhǎngyìzhìsùyújiǎzhuàngxiànjīnéngkàngjìndebiànhuà AT chénwěizhé xuèqīngzhōngdejīròushēngzhǎngyìzhìsùyújiǎzhuàngxiànjīnéngkàngjìndebiànhuà AT weichechen changeofserummyostaininpatientswithhyperthyroidism AT chénwěizhé changeofserummyostaininpatientswithhyperthyroidism |
_version_ |
1718069077225766912 |